Correlation
The correlation between CLOV and NKE is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
CLOV vs. NKE
Compare and contrast key facts about Clover Health Investments, Corp. (CLOV) and NIKE, Inc. (NKE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CLOV or NKE.
Performance
CLOV vs. NKE - Performance Comparison
Loading data...
Key characteristics
CLOV:
2.57
NKE:
-0.77
CLOV:
3.36
NKE:
-0.90
CLOV:
1.41
NKE:
0.86
CLOV:
2.23
NKE:
-0.46
CLOV:
11.55
NKE:
-1.33
CLOV:
18.44%
NKE:
23.96%
CLOV:
80.32%
NKE:
41.20%
CLOV:
-97.16%
NKE:
-75.58%
CLOV:
-85.68%
NKE:
-63.70%
Fundamentals
CLOV:
$1.63B
NKE:
$92.74B
CLOV:
-$0.04
NKE:
$3.01
CLOV:
1.10
NKE:
1.94
CLOV:
4.86
NKE:
6.62
CLOV:
$1.49B
NKE:
$47.82B
CLOV:
$391.93M
NKE:
$20.96B
CLOV:
-$22.89M
NKE:
$4.77B
Returns By Period
In the year-to-date period, CLOV achieves a -0.63% return, which is significantly higher than NKE's -18.39% return.
CLOV
-0.63%
-9.28%
-8.48%
203.88%
4.92%
N/A
N/A
NKE
-18.39%
6.78%
-20.77%
-31.72%
-17.91%
-7.97%
3.08%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CLOV vs. NKE — Risk-Adjusted Performance Rank
CLOV
NKE
CLOV vs. NKE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and NIKE, Inc. (NKE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CLOV vs. NKE - Dividend Comparison
CLOV has not paid dividends to shareholders, while NKE's dividend yield for the trailing twelve months is around 2.51%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 2.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NKE NIKE, Inc. | 2.51% | 2.00% | 1.28% | 1.07% | 0.68% | 0.71% | 0.89% | 1.11% | 1.18% | 1.30% | 0.93% | 1.04% |
Drawdowns
CLOV vs. NKE - Drawdown Comparison
The maximum CLOV drawdown since its inception was -97.16%, which is greater than NKE's maximum drawdown of -75.58%. Use the drawdown chart below to compare losses from any high point for CLOV and NKE.
Loading data...
Volatility
CLOV vs. NKE - Volatility Comparison
Clover Health Investments, Corp. (CLOV) has a higher volatility of 18.32% compared to NIKE, Inc. (NKE) at 11.89%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than NKE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CLOV vs. NKE - Financials Comparison
This section allows you to compare key financial metrics between Clover Health Investments, Corp. and NIKE, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CLOV vs. NKE - Profitability Comparison
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a gross profit of 108.89M and revenue of 462.33M. Therefore, the gross margin over that period was 23.6%.
NKE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, NIKE, Inc. reported a gross profit of 4.68B and revenue of 11.27B. Therefore, the gross margin over that period was 41.5%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported an operating income of -1.27M and revenue of 462.33M, resulting in an operating margin of -0.3%.
NKE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, NIKE, Inc. reported an operating income of 788.00M and revenue of 11.27B, resulting in an operating margin of 7.0%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a net income of -1.27M and revenue of 462.33M, resulting in a net margin of -0.3%.
NKE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, NIKE, Inc. reported a net income of 794.00M and revenue of 11.27B, resulting in a net margin of 7.1%.